Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy

Background: The strongest genetic determinant for multiple sclerosis (MS) is located at the human leukocyte antigen (HLA) class II DRB1 and DQB1 loci. Objectives: To investigate the possible role of predisposing HLA genotypes in determining brain atrophy. Methods: HLA genotypes were categorized as h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis 2019-01, Vol.25 (1), p.23-30
Hauptverfasser: Lorefice, Lorena, Fenu, Giuseppe, Sardu, Claudia, Frau, Jessica, Coghe, Giancarlo, Costa, Gianna, Schirru, Lucia, Secci, Maria Antonietta, Sechi, Vincenzo, Barracciu, Maria Antonietta, Marrosu, Maria Giovanna, Cocco, Eleonora
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 30
container_issue 1
container_start_page 23
container_title Multiple sclerosis
container_volume 25
creator Lorefice, Lorena
Fenu, Giuseppe
Sardu, Claudia
Frau, Jessica
Coghe, Giancarlo
Costa, Gianna
Schirru, Lucia
Secci, Maria Antonietta
Sechi, Vincenzo
Barracciu, Maria Antonietta
Marrosu, Maria Giovanna
Cocco, Eleonora
description Background: The strongest genetic determinant for multiple sclerosis (MS) is located at the human leukocyte antigen (HLA) class II DRB1 and DQB1 loci. Objectives: To investigate the possible role of predisposing HLA genotypes in determining brain atrophy. Methods: HLA genotypes were categorized as high risk (two predisposing haplotypes) or medium/low risk (one or no predisposing haplotypes). Patients underwent a brain magnetic resonance imaging (MRI) study and volumes of white matter (WM), gray matter (GM), and whole brain (WB) were estimated with SIENAX. Longitudinal atrophy was also assessed with SIENA. Results: The study included 240 MS patients. In 51/240 (21%) subjects, a high-risk HLA genotype was observed, while medium- and low-risk HLA genotypes were 109/240 (45%) and 80/240 (34%), respectively. Multiple regression analysis found that the high-risk HLA genotype was associated with significant reduction in WB (p = 0.02) and GM (p = 0.03) volumes compared with the medium-/low-risk HLA genotypes, independently from MS clinical features. The longitudinal study included 60 patients and showed a brain volume loss of −0.79% in high-risk HLA genotype group versus −0.56% in low-risk HLA genotype. Conclusion: Our results suggest an influence of HLA genotype on WB and GM atrophy. Further investigations are necessary to confirm these findings.
doi_str_mv 10.1177/1352458517739989
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1961641374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1352458517739989</sage_id><sourcerecordid>1961641374</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-3c3263fbaf0dbb997fae6fef0415c0ff6b74b44dcf5d84dd14eaaee054fdc6ae3</originalsourceid><addsrcrecordid>eNp1kDFPwzAQhS0EoqWwMyFLLCwBX-zEMVtVAUUUscAcOc65pEqdECdD_z2uWkCqxHRPuu-9Oz1CLoHdAkh5BzyJRZIlQXOlMnVExiCkjJiS7DjosI62-xE5837FGAtcckpGsQKALONj8vI61H3V1ki9qbFrfOWpdiWdL6Z0ia7pNy36ezqlbeN9VQSucrYe0BmkjaNFpytHdd817efmnJxYXXu82M8J-Xh8eJ_No8Xb0_NsuoiM4NBH3PA45bbQlpVFoZS0GlOLlglIDLM2LaQohCiNTcpMlCUI1BqRJcKWJtXIJ-Rml9t2zdeAvs_XlTdY19phM_gcVAqpAC5FQK8P0FUzdC58l8cgWcyVBBUotqNMKMB3aPO2q9a62-TA8m3R-WHRwXK1Dx6KNZa_hp9mAxDtAK-X-Hf138Bv_oOFyA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2170239719</pqid></control><display><type>article</type><title>Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy</title><source>SAGE Complete A-Z List</source><source>MEDLINE</source><creator>Lorefice, Lorena ; Fenu, Giuseppe ; Sardu, Claudia ; Frau, Jessica ; Coghe, Giancarlo ; Costa, Gianna ; Schirru, Lucia ; Secci, Maria Antonietta ; Sechi, Vincenzo ; Barracciu, Maria Antonietta ; Marrosu, Maria Giovanna ; Cocco, Eleonora</creator><creatorcontrib>Lorefice, Lorena ; Fenu, Giuseppe ; Sardu, Claudia ; Frau, Jessica ; Coghe, Giancarlo ; Costa, Gianna ; Schirru, Lucia ; Secci, Maria Antonietta ; Sechi, Vincenzo ; Barracciu, Maria Antonietta ; Marrosu, Maria Giovanna ; Cocco, Eleonora</creatorcontrib><description>Background: The strongest genetic determinant for multiple sclerosis (MS) is located at the human leukocyte antigen (HLA) class II DRB1 and DQB1 loci. Objectives: To investigate the possible role of predisposing HLA genotypes in determining brain atrophy. Methods: HLA genotypes were categorized as high risk (two predisposing haplotypes) or medium/low risk (one or no predisposing haplotypes). Patients underwent a brain magnetic resonance imaging (MRI) study and volumes of white matter (WM), gray matter (GM), and whole brain (WB) were estimated with SIENAX. Longitudinal atrophy was also assessed with SIENA. Results: The study included 240 MS patients. In 51/240 (21%) subjects, a high-risk HLA genotype was observed, while medium- and low-risk HLA genotypes were 109/240 (45%) and 80/240 (34%), respectively. Multiple regression analysis found that the high-risk HLA genotype was associated with significant reduction in WB (p = 0.02) and GM (p = 0.03) volumes compared with the medium-/low-risk HLA genotypes, independently from MS clinical features. The longitudinal study included 60 patients and showed a brain volume loss of −0.79% in high-risk HLA genotype group versus −0.56% in low-risk HLA genotype. Conclusion: Our results suggest an influence of HLA genotype on WB and GM atrophy. Further investigations are necessary to confirm these findings.</description><identifier>ISSN: 1352-4585</identifier><identifier>EISSN: 1477-0970</identifier><identifier>DOI: 10.1177/1352458517739989</identifier><identifier>PMID: 29111883</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Atrophy ; Brain ; Drb1 protein ; Female ; Genotype &amp; phenotype ; Genotypes ; Gray Matter - diagnostic imaging ; Gray Matter - pathology ; Haplotypes ; Histocompatibility antigen HLA ; HLA-D Antigens - genetics ; HLA-DQ beta-Chains - genetics ; HLA-DRB1 Chains - genetics ; Humans ; Italy ; Longitudinal Studies ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple regression analysis ; Multiple sclerosis ; Multiple Sclerosis - diagnostic imaging ; Multiple Sclerosis - genetics ; Multiple Sclerosis - pathology ; Neuroimaging ; NMR ; Nuclear magnetic resonance ; Substantia alba ; Substantia grisea ; White Matter - diagnostic imaging ; White Matter - pathology</subject><ispartof>Multiple sclerosis, 2019-01, Vol.25 (1), p.23-30</ispartof><rights>The Author(s), 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-3c3263fbaf0dbb997fae6fef0415c0ff6b74b44dcf5d84dd14eaaee054fdc6ae3</citedby><cites>FETCH-LOGICAL-c431t-3c3263fbaf0dbb997fae6fef0415c0ff6b74b44dcf5d84dd14eaaee054fdc6ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1352458517739989$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1352458517739989$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29111883$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lorefice, Lorena</creatorcontrib><creatorcontrib>Fenu, Giuseppe</creatorcontrib><creatorcontrib>Sardu, Claudia</creatorcontrib><creatorcontrib>Frau, Jessica</creatorcontrib><creatorcontrib>Coghe, Giancarlo</creatorcontrib><creatorcontrib>Costa, Gianna</creatorcontrib><creatorcontrib>Schirru, Lucia</creatorcontrib><creatorcontrib>Secci, Maria Antonietta</creatorcontrib><creatorcontrib>Sechi, Vincenzo</creatorcontrib><creatorcontrib>Barracciu, Maria Antonietta</creatorcontrib><creatorcontrib>Marrosu, Maria Giovanna</creatorcontrib><creatorcontrib>Cocco, Eleonora</creatorcontrib><title>Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy</title><title>Multiple sclerosis</title><addtitle>Mult Scler</addtitle><description>Background: The strongest genetic determinant for multiple sclerosis (MS) is located at the human leukocyte antigen (HLA) class II DRB1 and DQB1 loci. Objectives: To investigate the possible role of predisposing HLA genotypes in determining brain atrophy. Methods: HLA genotypes were categorized as high risk (two predisposing haplotypes) or medium/low risk (one or no predisposing haplotypes). Patients underwent a brain magnetic resonance imaging (MRI) study and volumes of white matter (WM), gray matter (GM), and whole brain (WB) were estimated with SIENAX. Longitudinal atrophy was also assessed with SIENA. Results: The study included 240 MS patients. In 51/240 (21%) subjects, a high-risk HLA genotype was observed, while medium- and low-risk HLA genotypes were 109/240 (45%) and 80/240 (34%), respectively. Multiple regression analysis found that the high-risk HLA genotype was associated with significant reduction in WB (p = 0.02) and GM (p = 0.03) volumes compared with the medium-/low-risk HLA genotypes, independently from MS clinical features. The longitudinal study included 60 patients and showed a brain volume loss of −0.79% in high-risk HLA genotype group versus −0.56% in low-risk HLA genotype. Conclusion: Our results suggest an influence of HLA genotype on WB and GM atrophy. Further investigations are necessary to confirm these findings.</description><subject>Adult</subject><subject>Atrophy</subject><subject>Brain</subject><subject>Drb1 protein</subject><subject>Female</subject><subject>Genotype &amp; phenotype</subject><subject>Genotypes</subject><subject>Gray Matter - diagnostic imaging</subject><subject>Gray Matter - pathology</subject><subject>Haplotypes</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA-D Antigens - genetics</subject><subject>HLA-DQ beta-Chains - genetics</subject><subject>HLA-DRB1 Chains - genetics</subject><subject>Humans</subject><subject>Italy</subject><subject>Longitudinal Studies</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiple regression analysis</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - diagnostic imaging</subject><subject>Multiple Sclerosis - genetics</subject><subject>Multiple Sclerosis - pathology</subject><subject>Neuroimaging</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Substantia alba</subject><subject>Substantia grisea</subject><subject>White Matter - diagnostic imaging</subject><subject>White Matter - pathology</subject><issn>1352-4585</issn><issn>1477-0970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kDFPwzAQhS0EoqWwMyFLLCwBX-zEMVtVAUUUscAcOc65pEqdECdD_z2uWkCqxHRPuu-9Oz1CLoHdAkh5BzyJRZIlQXOlMnVExiCkjJiS7DjosI62-xE5837FGAtcckpGsQKALONj8vI61H3V1ki9qbFrfOWpdiWdL6Z0ia7pNy36ezqlbeN9VQSucrYe0BmkjaNFpytHdd817efmnJxYXXu82M8J-Xh8eJ_No8Xb0_NsuoiM4NBH3PA45bbQlpVFoZS0GlOLlglIDLM2LaQohCiNTcpMlCUI1BqRJcKWJtXIJ-Rml9t2zdeAvs_XlTdY19phM_gcVAqpAC5FQK8P0FUzdC58l8cgWcyVBBUotqNMKMB3aPO2q9a62-TA8m3R-WHRwXK1Dx6KNZa_hp9mAxDtAK-X-Hf138Bv_oOFyA</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Lorefice, Lorena</creator><creator>Fenu, Giuseppe</creator><creator>Sardu, Claudia</creator><creator>Frau, Jessica</creator><creator>Coghe, Giancarlo</creator><creator>Costa, Gianna</creator><creator>Schirru, Lucia</creator><creator>Secci, Maria Antonietta</creator><creator>Sechi, Vincenzo</creator><creator>Barracciu, Maria Antonietta</creator><creator>Marrosu, Maria Giovanna</creator><creator>Cocco, Eleonora</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20190101</creationdate><title>Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy</title><author>Lorefice, Lorena ; Fenu, Giuseppe ; Sardu, Claudia ; Frau, Jessica ; Coghe, Giancarlo ; Costa, Gianna ; Schirru, Lucia ; Secci, Maria Antonietta ; Sechi, Vincenzo ; Barracciu, Maria Antonietta ; Marrosu, Maria Giovanna ; Cocco, Eleonora</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-3c3263fbaf0dbb997fae6fef0415c0ff6b74b44dcf5d84dd14eaaee054fdc6ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Atrophy</topic><topic>Brain</topic><topic>Drb1 protein</topic><topic>Female</topic><topic>Genotype &amp; phenotype</topic><topic>Genotypes</topic><topic>Gray Matter - diagnostic imaging</topic><topic>Gray Matter - pathology</topic><topic>Haplotypes</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA-D Antigens - genetics</topic><topic>HLA-DQ beta-Chains - genetics</topic><topic>HLA-DRB1 Chains - genetics</topic><topic>Humans</topic><topic>Italy</topic><topic>Longitudinal Studies</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiple regression analysis</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - diagnostic imaging</topic><topic>Multiple Sclerosis - genetics</topic><topic>Multiple Sclerosis - pathology</topic><topic>Neuroimaging</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Substantia alba</topic><topic>Substantia grisea</topic><topic>White Matter - diagnostic imaging</topic><topic>White Matter - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lorefice, Lorena</creatorcontrib><creatorcontrib>Fenu, Giuseppe</creatorcontrib><creatorcontrib>Sardu, Claudia</creatorcontrib><creatorcontrib>Frau, Jessica</creatorcontrib><creatorcontrib>Coghe, Giancarlo</creatorcontrib><creatorcontrib>Costa, Gianna</creatorcontrib><creatorcontrib>Schirru, Lucia</creatorcontrib><creatorcontrib>Secci, Maria Antonietta</creatorcontrib><creatorcontrib>Sechi, Vincenzo</creatorcontrib><creatorcontrib>Barracciu, Maria Antonietta</creatorcontrib><creatorcontrib>Marrosu, Maria Giovanna</creatorcontrib><creatorcontrib>Cocco, Eleonora</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Multiple sclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lorefice, Lorena</au><au>Fenu, Giuseppe</au><au>Sardu, Claudia</au><au>Frau, Jessica</au><au>Coghe, Giancarlo</au><au>Costa, Gianna</au><au>Schirru, Lucia</au><au>Secci, Maria Antonietta</au><au>Sechi, Vincenzo</au><au>Barracciu, Maria Antonietta</au><au>Marrosu, Maria Giovanna</au><au>Cocco, Eleonora</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy</atitle><jtitle>Multiple sclerosis</jtitle><addtitle>Mult Scler</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>25</volume><issue>1</issue><spage>23</spage><epage>30</epage><pages>23-30</pages><issn>1352-4585</issn><eissn>1477-0970</eissn><abstract>Background: The strongest genetic determinant for multiple sclerosis (MS) is located at the human leukocyte antigen (HLA) class II DRB1 and DQB1 loci. Objectives: To investigate the possible role of predisposing HLA genotypes in determining brain atrophy. Methods: HLA genotypes were categorized as high risk (two predisposing haplotypes) or medium/low risk (one or no predisposing haplotypes). Patients underwent a brain magnetic resonance imaging (MRI) study and volumes of white matter (WM), gray matter (GM), and whole brain (WB) were estimated with SIENAX. Longitudinal atrophy was also assessed with SIENA. Results: The study included 240 MS patients. In 51/240 (21%) subjects, a high-risk HLA genotype was observed, while medium- and low-risk HLA genotypes were 109/240 (45%) and 80/240 (34%), respectively. Multiple regression analysis found that the high-risk HLA genotype was associated with significant reduction in WB (p = 0.02) and GM (p = 0.03) volumes compared with the medium-/low-risk HLA genotypes, independently from MS clinical features. The longitudinal study included 60 patients and showed a brain volume loss of −0.79% in high-risk HLA genotype group versus −0.56% in low-risk HLA genotype. Conclusion: Our results suggest an influence of HLA genotype on WB and GM atrophy. Further investigations are necessary to confirm these findings.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>29111883</pmid><doi>10.1177/1352458517739989</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1352-4585
ispartof Multiple sclerosis, 2019-01, Vol.25 (1), p.23-30
issn 1352-4585
1477-0970
language eng
recordid cdi_proquest_miscellaneous_1961641374
source SAGE Complete A-Z List; MEDLINE
subjects Adult
Atrophy
Brain
Drb1 protein
Female
Genotype & phenotype
Genotypes
Gray Matter - diagnostic imaging
Gray Matter - pathology
Haplotypes
Histocompatibility antigen HLA
HLA-D Antigens - genetics
HLA-DQ beta-Chains - genetics
HLA-DRB1 Chains - genetics
Humans
Italy
Longitudinal Studies
Magnetic Resonance Imaging
Male
Middle Aged
Multiple regression analysis
Multiple sclerosis
Multiple Sclerosis - diagnostic imaging
Multiple Sclerosis - genetics
Multiple Sclerosis - pathology
Neuroimaging
NMR
Nuclear magnetic resonance
Substantia alba
Substantia grisea
White Matter - diagnostic imaging
White Matter - pathology
title Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A23%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20sclerosis%20and%20HLA%20genotypes:%20A%20possible%20influence%20on%20brain%20atrophy&rft.jtitle=Multiple%20sclerosis&rft.au=Lorefice,%20Lorena&rft.date=2019-01-01&rft.volume=25&rft.issue=1&rft.spage=23&rft.epage=30&rft.pages=23-30&rft.issn=1352-4585&rft.eissn=1477-0970&rft_id=info:doi/10.1177/1352458517739989&rft_dat=%3Cproquest_cross%3E1961641374%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2170239719&rft_id=info:pmid/29111883&rft_sage_id=10.1177_1352458517739989&rfr_iscdi=true